OQROGet OQRO Pro
Insider trade

Crispr Therapeutics Ag (CRSP)Chief Operating Officer sold ~$71K

Julianne Bruno, Chief Operating Officer at Crispr Therapeutics Ag, sold ~$71K of Crispr Therapeutics Ag shares.

~$71K
Approx. value · 1,714 sh @ $41.23
11K
Holds after · shares reported
Traded
Mar 21, 2025
Filed
Mar 24, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Feb 18, 2025Insider · 2 peopleInsiders: 2 sales (~$1.2M)
  2. Feb 19, 2025Insider · 3 peopleInsiders: 4 sales (~$1.5M)
  3. Feb 26, 2025InsiderDirector purchased ~$314K of CRSP shares in the open market
  4. Mar 11, 2025Insider · 3 peopleInsiders: 3 sales (~$595K)
  5. Mar 12, 2025Insider · 3 peopleInsiders: 3 sales (~$250K)
  6. Mar 17, 2025InsiderCFO sold ~$157K of CRSP shares in the open market
  7. Mar 21, 2025 · this disclosureInsiderOfficer sold ~$71K of CRSP shares in the open market

What came next

  1. Mar 21, 2025Insider · 3 peopleInsiders: 3 sales (~$635K)
  2. May 29, 2025InsiderOfficer sold ~$141K of CRSP shares in the open market
  3. Jul 16, 2025Insider · 1 personInsiders: 3 purchases (~$51.5M)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Crispr Therapeutics Ag

For Crispr Therapeutics Ag, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 3 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CRSP page.

Other recent filings by Julianne Bruno, Chief Operating Officer

The full history of Julianne Bruno, Chief Operating Officer is on the profile page.

How this filing works

Other disclosures at Crispr Therapeutics Ag

Everything OQRO holds on this company is on its CRSP page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data